Membership

The following individuals are Members of the IDEAL Collaboration.  Membership of IDEAL indicates the named Member’s personal support for the principles of the IDEAL Collaboration described here. Membership does not imply any endorsement by the IDEAL Collaboration of any products or services provided by Members or their employers.

If you are interested in joining, please use the feedback form at the bottom of this page to get in touch.

Chair: Mr Peter McCulloch, Nuffield Department of Surgical Sciences, University of Oxford

Vice-Chair: Dr Art Sedrakyan, Weill Cornell Medical College, New York

Members:

  • Dr Riaz Agha, Founder, International Journal of Surgery and Annals of Medicine and Surgery; Plastic Surgery
  • Dr Hashim Uddin Ahmed, MRC Clinician Scientist, University College London
  • Prof Doug Altman, Director of Centre for Statistics in Medicine; Statistics
  • Dr Mario Ammirati, Chairman Neurosurgery Department Mercy Health/St Rita Medical Center, Ohio
  • Prof Jeff Aronson, Reader in Clinical Pharmacology, Honorary Consultant in Clinical Pharmacology, Honorary Consultant Physician; Clinical pharmacology, general medicine
  • Prof Carol Ashton, John F. Jr. and Carolyn Bookout Prof of Surgical Quality & Outcomes Science and Co-Director, Center for Outcomes Research, Houston Methodist Hospital Research Institute, Houston, Texas
  • Prof Augusto Azuara-Blanco, Professor of Ophthalmology at Queen’s University Belfast, (and Honorary Consultant Ophthalmologist at the BHSCT) Surgical interest in Eye Surgery
  • Dr Chris Bainbridge, Consultant hand surgeon, Pulvertaft Hand Centre, Royal Derby Hospital, Derby (Dupuytrens and peripheral nerve entrapment)
  • Julie Bakobaki, Clinical Trials Operations Manager, University College London
    Clinical Trials Unit.
  • Prof Jeffrey Barkun, Professor of Surgery, McGill University
  • Dr Dimitri Barski, Dept of Urology, Lukas Hospital Neuss, Germany
  • Prof Michael Baum, Professor Emeritus of Surgery; Surgical oncology, breast surgery
  • Prof David Beard, Professor of Musculoskeletal Sciences, Director of OSIRIS; Orthopaedic surgery
  • Dr Elena Berti, Regional Agency for Health and Social Care (ASSR), Emilia-Romagna, Bologna, Italy (HTA/health service quality evaluation)
  • Prof Gwyn Bevan, Professor of Policy Analysis, Head of Dept of Management, London School of Economics; Health economics
  • Dr Mohit Bhandari, McMaster University;  Orthopaedic surgery
  • Prof Jane Blazeby,  Director of Surgical Trials Centre, University of Bristol; Upper GI surgery
  • Ms Natalie Bohm, Clinical academic lecturer, University College London; ENT surgery
  • Prof Isabelle Boutron, CONSORT, EQUATOR Paris Descartes Univ; French Cochrane Centre
  • Dr Savtaj Brar, Clinical Associate, Surgical Oncology, Mount Sinai Hospital, University of Toronto, Canada
  • Dr Carl J. Brown, Head, Division of General Surgery, Providence Health Care Specialist in General and Colorectal Surgery, St. Paul’s Hospital Chief, Section of Colorectal Surgery, University of BC Clinical Research Scientist, Centre for Health Evaluation and Outcomes Research (Transanal Endoscopic Microsurgery/TaTME)
  • Prof Markus Buechler, Director of General, Visceral and Transplantation Surg; GI, hepatobiliary and transplant surgery (pancreas transplant)
  • Dr Hiske Calsbeek, Senior Researcher, Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands (special interest Perioperative Patient Safety)
  • Prof Bruce Campbell, Chair, Interventional Technologies Panel for NHS Health Technology Assessment;  Vascular surgery
  • Prof Andrew Carr, Head of Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University; Orthopaedic surgery
  • Dr Kalipso Chalkidou, Founding director of UK NHS National Insitute of Clinical Excellence’s international programme
  • Prof Pierre-Alain Clavien, Univ Hospital of Zurich, Clavien-Dindo classification of surgical complications;  Transplant surgery
  • Dr Tammy Clifford, Vice president of HTA at the Canadian Agency for Drugs and Technology in Health (CADTH);  Epidemiology
  • Dr Jonathan Cook, University of Oxford; Methodology
  • Dr Andrew Currie, Minimally Invasive GI Surgical Research Fellow, St Mark’s Hospital, Harrow, UK
  • Dr Pierre Dagenais, Montreal;  Methodology
  • Dr Philipp Dahm, Professor of Urology & Vice-Chair of Veterans Affairs, University of Minnesota, Director for Surgery/Specialty Care Service Line Research Activities and Coordinating Editor,  Cochrane Prostatic Diseases & Urological Cancers (PDUC) Group
  • Dr Peter Davidson, Director, UK NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC); General medicine

  • Dr Hugh Davies, Research ethics adviser, National Research Ethics Service (NRES);  Respiratory paediatric medicine

  • Dr Alessandro De Mauro, Vicomtech, San Sebastien, Spain

  • Dr Markus Diener, University of Heidelberg

  • Dr Kate Duhig, Academic Clinical Fellow, Academic Dept of Women’s Health, St Thomas’ Hospital, King’s College London
  • Mr Jonothan Earnshaw, Joint chief editor, British Journal of Surgery;  Vascular surgery
  • Dr Neil Ebenezer, Head of New and Emerging Technologies, Medicines and Healthcare Regulatory Agency (MHRA)
  • Priv.-Doz. Dr. med. habil. Thorsten Ecke, Dept. of Urology, HELIOS Hospital Bad Saarow, Germany
  • Dr Patrick Ergina, Prof of cardiothoracic surgery, McGill University; Cardiothoracic surgery
  • Prof Chris Evans, Dept. of Emergency Medicine, SE Ontario Trauma Program, Kingston General Hospital, ON, Canada
  • Joshua Feinberg, IDEAL Clinical Research Fellow in EBM, Maimonides Medical Center, Brooklyn, New York (patient safety and practical application of IDEAL Framework in surgical innovation)
  • Dr Shamiram Feinglass, Vice President for Global Medical & Regulatory Affairs, Zimmer medical devices
  • Prof Liane Feldman, McGill University;  Minimally invasive surgery
  • Prof Secundino Fernandez, Professor, University of Navarra and Surgeon (Otolaryngology and Head and Neck) Pamplona, Spain
  • Dr Abraham Fingerhut
  • Prof David Flum, Director of the Surgical Outcomes Research Center (SORCE), University of Washington; GI, bariatricsurgery
  • Prof Clifton David Fuller, The University of Texas M.D. Anderson Cancer Center
    Department of Radiation Oncology, Graduate School of Biomedical Sciences at Houston, Texas, USA
  • Dr Jose Carlos Garcia Jr, University of Sao Paulo, Laboratory of Surgical Pathophysiology, Brazil
  • Prof Herney Andrés García-Perdomo, Professor of Urology and Clinical Epidemiology at University of Valle (Cali, Colombia) and coordinates the Associate Cochrane Group
  • Mr Matthew Gardiner, Specialty Registrar in Plastic Surgery, Broomfield Hospital (interests: plastic surgery, hand surgery)
  • Dr Holger Gerullis (PhD), University Hospital for Urology, Klinikum Oldenburg, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Germany
  • Dr Khurshid R. Ghani, Assistant Professor, Dept of Urology, University of Michigan, Ann Arbor, MI, USA. (kidney transplantation).
  • Kathryn Gill, Consultant Colorectal Surgeon, Chair, Research and Development Committee, Pelvic Floor Society, Sandwell and West Birmingham Hospitals NHS Trust, UK
  • Prof Paul Glasziou, Professor, Bond University; former director of CEBM, GP
  • Mr Sion Glyn-Jones, Senior clinical lecturer, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University; Orthopaedic surgery
  • Sir Muir Gray, Director, Better Value Healthcare; Public health
  • Prof Damian Griffin, Professor of Trauma and Orthopaedic Surgery, Division of Health Sciences, Warwick Medical School, UK
  • Ms Trish Groves, Deputy editor BMJ and editor-in-chief BMJ Open; Psychiatry
  • Dr Emma Hall, Reader of Oncology Trials, Institute of Cancer Research Clinical Trials and Statistics Unit, London (oncology trials, evaluation of new radiation technologies)
  • Prof Alison Halliday, Prof of Vascular Surgery, University of Oxford; Vascular surgery
  • Prof Freddie Hamdy, Head of Nuffield Department of Surgery, Professor of Urology, University of Oxford;  Urological surgery
  • Dr Judith Hargreaves, Director, Health Economics and Reimbursement, Covidien.
  • Dr Ted Heise, Vice President Regulatory Science, Cook Medical
  • Dr Carl Heneghan, Director, Centre for Evidence-Based Medicine, University of Oxford;  Epidemiology
  • Florian Herrle, Surgical Department, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany. (special hernia and endocrine surgery, colorectal surgery, CIBD, abdominal sepsis. EBM in surgery, systematic reviews/RCTs, information mastery and knowledge transfer, surgical decision making)
  • Dr Jo Carol Hiatt; Chair, Kaiser Permanente National Product Council; Chair, Interregional New Technologies Committee; Assistant Medical Director, Southern California Permanente Medical Group;     General surgery
  • Prof Tracey Howe;  Glasgow Caledonian University and Cochrane Musculoskeletal Group;  Musculoskeletal.
  • Jacqueline Hughes; Clinical Coordinator, Strathclyde Institute of Medical Devices, Department of Biomedical Engineering, University of Strathclyde, Glasgow, Scotland
  • Dr Jessica Jalbert, Director of Pharmacoepidemiology US, LASER Analytica, New York, NY and Assistant Professor (courtesy) Weill Cornell Medical College, New York, NY
  • Dr Teppo Järvinen, MD, Adjunct Professor (Orthopaedics), University of Helsinki and Helsinki University Central Hospital, Finland
  • Emma Jones, Health Foundation Doctoral Research Fellow (Leicester University) and Extended Scope Physiotherapist – orthopaedic directorate (University Hospitals Leicester NHS Trust). PhD thesis working title: SIQINS: Strengthening Implementation of Quality Improvement Interventions and Methods in Surgery. Also interested in Patient and Public Involvement
  • Dr Daniyar Jumaniyazov;  Director, Altaco XXI, Kazakhstan;  Distributor of stem cell products for research.
  • Dr Lileswar Kaman, Additional Professor, Department of General Surgery, PGIMER, Chandigarh, INDIA. (Hepatobilliary Pancreatic surgery/Liver Transplant)
  • Mr Sean Kehoe, Lawson Tait Professor of Gynaecological Cancer, University of Birmingham and Senior Research Fellow, St.Peters College, Oxford
  • Mr Angelos Kolias, NIHR Academic Clinical Registrar in Neurosurgery, University of Cambridge; lead, British Neurosurgical Trainee Research Collaborative
  • Professor Anthony King, Consultant Ophthalmologist, Nottingham University Hospital, Honorary Professor Clinical Ophthalmology, University of Nottingham, UK (Interest;  glaucoma surgery)
  • Dr Richard Kuntz, Senior Vice President and Chief Scientific, Clinical and  Regulatory Officer, Medtronic Inc.; Interventional cardiology
  • Dr Rachel Kwon, Clinical Research Fellow, Nuffield Department of Surgical Sciences, University of Oxford; General surgical trainee, Maimonides Medical Center
  • Joey Kwong, Assoc. Prof, Executive Associate Director, Chinese Cochrane Center and Chinese EBM Center, West China Hospital, Sichuan University, Chengdu, China (post market safety evaluation of cardiovascular medical devices)
  • Prof Sallie Lamb, Director, Warwick Clinical Trials Unit, University of Warwick
  • Prof Peter Lees, Founding Director of Faculty of Medical Leadership and Management, Neurosurgery
  • Dr Richard Lehman
  • Dr Tom Lehnert
  • Dr Nicola Lennard, Medicines and Healthcare Regulatory Agency (MHRA); Vascular surgery
  • Prof Richard Lilford, Health Techhology Assessment, University of Birmingham,    Chair, NIHR Methodology Panel; Ob/gyn, Epidemiology
  • Dr Mario Henrique Lobão Gonçalves, Orthopedic surgeon/researcher, Center for Advanced Studies in Orthopedics (NÆON) in São Paulo, Brazil.(Shoulder Instability, Rotator Cuff Repair, Trauma, Arthroscopy and Robotic Endoscopic Procedures)
  • Dr Susanne Ludgate, MHRA (retired)
  • Dr Georgios Lyratzopoulos, University of Cambridge;  Public health
  • Karen Macpherson, Lead Health Services Researcher, Scottish Health Technologies Group (HTA specifically non-pharmaceutical technologies, Health Services Research, Systematic Reviewing)
  • Prof Guy Maddern, University of Adelaide, Surgical director, Australian Safety and Efficacy Register of New Interventional Procedures (ASERNIP); Hepatobiliary surgery
  • Prof Rajan Madhok, Medical Director of NHS Manchester; Orthopaedic surgery, Public health
  • Gurdeep Mannu, Clinical Research Fellow, General Surgery, University of Oxford. (Interest: assessment of efficacy in surgical studies and evidence-based practice of general surgery)
  • Dr Danica Marinac-Dabic, US FDA, Director, Division of Epidemiology, Center for Devices and Radiological Health
  • Mr Andrew McCombe, Honorary Secretary, ENT UK;  ENT surgeon
  • Dr Richard McGee, Sydney School of Public Health, University of Sydney
  • Dr David R. McGowan, Surgical Trainee, Sheffield teaching Hospitals NHS Foundation Trust, (ENT Surgery, surgical outcomes, human factors)
  • Heather McIntosh, Health Services Researcher, Healthcare Improvement Scotland, Glasgow
  • Prof Klim McPherson, Visiting Professor in Epidemiology, University of Oxford;  Ob/gyn, (epidemiology)
  • Prof Jonathan Meakins, Former Head of Nuffield Department of Surgery, University of Oxford;  Laparoscopic, transplant surgery
  • Prof Mani Menon,The Raj and Padma Vattikuti Distinguished Chair,Director, Vattikuti Urology Institute, Henry Ford Hospital, MI, USA (kidney transplantation)
  • Luis Rafael Moscote-Salazar, Neurosurgeon/Intensivist, Clinica Universitaria de Puerto Montt, Chile
  • Dr Richard Naspro, Urological Surgeon, Department of Urology, Papa Giovanni XXIII Hospital (HPG23), Bergamo, Italy
  • Dr Ionut Negoi, MD, Senior Lecturer of General Surgery, Carol Davila University of Medicine and Pharmacy, Attending General Surgeon, Emergency Hospital of Bucharest, Romania. (surgical oncology, and hepatobiliary and pancreatic surgery)
  • Prof Rob Nelissen, Professor Orthopaedics Leiden University Medical Center
    Medical Delta professor
  • Ms Pam Nevar, Managing editor, Annals of Surgery
  • Dr Jon Nicholl, Director of the NIHR School for Public Health Research, Sheffield University;  Medical statistics
  • Dr Matthew Nielsen, Director of Urologic Oncology, University of North Carolina Lineberger Comprehensive Cancer Center (clinical epidemiology, cancer care quality and medical decision making, focus on bladder and prostate cancer).
  • Dr Neil Ogden, Chief, General Surgery Devices, Office of Device Evaluation, Food and Drug Administration, MD., USA
  • Dr Markus Ott, Vice President EMEA Health Economics, Policy & Reimbursement, Covidien
  • Dr Arsenio Paez, LEND Fellow in Neuordevelopmental Disabilities., Professor at Northeastern University, Department of Physical Therapy, Movement and Rehabilitation Sciences, Boston, MA (Rehab, Disability and Neurodegenerative disorders)
  • Christopher Pennell, IDEAL Clinical Research Fellow in EBM, Maimonides Medical Center, Brooklyn, New York. (medical device evaluation and practical application of IDEAL Framework in surgical innovation)
  • Dr Erlick Pereira, Dept of Neurosurgery, Oxford University Hospitals
  • Mr David Plotts, Director for Northern Europe & UK Managing Director, Aerocrine; former UK Host Manager & UK Board Director, Covidien
  • Julie Polisena, Scientific Advisor, Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada
  • Prof Andrew Price,  Professor of Orthopaedic Surgery, University of Oxford;      Orthopaedic surgery
  • Prof Amar Rangan, Clinical Professor of Trauma & Orthopaedic Surgery, School of Medicine & Health, Durham University. Chairman, Research Committee of The British Orthopaedic Association.
  • Dr Patta Radhakrishna, Chennai, India (abdominal surgery)
  • Manoj J. Raval, Specialist in General & Colorectal Surgery, Clinical Associate Professor, University of British Columbia, Chair, BC Cancer Agency Surgical Oncology Network Colorectal Surgery Tumour Group and Clinical Research Scientist, Centre for Health Evaluation and Outcome Science, St. Paul’s Hospital, Vancouver, BC, Canada
  • Mr Rowland Rees, consultant urological surgeon, University Hospital Southampton
  • Dr Drummond Rennie, Emeritus editor in chief, Annals of Surgery
  • Dr Iain Robertson, Chair of the Scottish Health Technology Group. Healthcare Improvement Scotland
  • Prof Maroeska Rovers, Professor evidence-based surgery, Radboud University Medical Center, Nijmegen, The Netherlands
  • Suzanne Ryan, Nurse Unit Manager – Research, Surgical Service Group, Sunshine Coast Hospital & Health Service, Queensland Australia
  • Prof David Sackett, Professor Emeritus, Clinical Epidemiology & Biostatistics;    Internal medicine, nephrology
  • Dr Dan Schaber, Vice President for Clinical Research, Medtronic
  • Prof Markus Schafer, Program Director and Head of Upper GI/Pancreas Surgery, University Hospital of Lausanne, Switzerland (systematic reviews and meta-analysis)
  • Prof Anne Schilder, Director of UCLP’s ENT Clinical Trials Programme, University College London; ENT surgeon
  • Dr Frank Schuller
  • Dr Art Sedrakyan, Associate Professor of Public Health and Cardiothoracic Surgery, Weill Cornell Medical College, New York, NY (with special interest in medical devices and regulation).
  • Prof Christoph Seiler, University of Heidelberg
  • Dr Shafaque Shaikh, NIHR Academic Clinical Lecturer in Colorectal Surgery, University of Leeds, UK (metabolic targets CRC, host response CRC, acute diverticulitis)
  • Dr Daniella Smolenska, Regulatory affairs manager, MHRA
  • Dr Akshay Sood, Postdoctoral Research Fellow, Henry Ford Hospital. VUI.  (Transplantation)
  • Dr Bill Summerskill, Executive editor, the Lancet; Primary care
  • Prof David Taggart, Professor of Cardiovascular Surgery, University of Oxford;   Cardiovascular surgery
  • Casper Tax, MD, PhD candidate on Evidence Based Surgery, Radboud University Medical Center, Nijmegen, The Netherlands
  • Prof Douglas Tincello, Prof of Uro-gynaecology, Associate Lead for Clinical Research, Dept of Health Sciences, College of Medicine, University of Leicester, UK
  • Dr David Tivey, Royal Australasian College of Surgeons and Joanna Briggs Institute, University of Adelaide, Australia (HTA and systematic review of surgical research 
  • Dr William D. Toff, Assoc Prof Cardiology, Dept of Cardiovascular Sciences, University of Leicester, UK
  • Dr David Tolley, Royal College of Surgeons of Edinburgh;  Urological surgery
  • Dr Olga Tucker, GI Surgeon, Queen Elizabeth Hospital, University of Birmingham
  • Dr Joost J. van Middendorp, Research Director, Stoke Mandeville Spinal Foundation and Research Fellow, University of Oxford
  • Prof Jayant Vaidya, Scientific Director, Clinical Trials Group, Surgery and Interventional Science, University College London. Consultant Surgeon. (Breast cancer)
  • Prof Jan Vandenbroucke, Professor of Clinical Epidemiology, University of Leiden
  • HM (Lenny) Verkooijen, Associate Professor of Clinical Epidemiology, University Medical Center Utrecht, the Netherlands (special interest: clinical evaluation of (image-guided) oncological interventions)
  • Dr Bolívar A. Villacís, Guayaquil, Guayas, Ecuador
  • Dr Nicola Vousden, Academic Clinical Fellow, Academic Dept of Women’s Health, St Thomas’ Hospital, King’s College London
  • Prof Tom Walley, University of Liverpool, Director of Health Technology Assessment
  • Prof Rebecca Wong, Vice chair for education and Director for clinical trials, University of Toronto, Department of Radiation Oncology, Princess Margaret Cancer Center
  • Prof Nelda Wray, Co-Director, Center for Outcomes Research, Research Professor of Medicine in Surgery, Methodist Instit. for Technology, Houston, Texas, USA
  • Dr. Induprabha Yadev, Assistant Professor, Dept of Surgery, Government Medical College, Trivandrum, Kerala, India (thyroid disease)
  • Dr Kaissar Yammine, Director, Center of Evidence-Based Sport and Orthopedic Research (CEBSOR), Emirates Hospital, Dubai
  • Dr Gustavo Zanoli, Surgical Editor, Cochrane Musculoskeletal Group, Italy

Download the August 2015 Members Survey here  IDEAL Members Survey_Aug15

One thought on “Membership

  1. Chair of the Scottish Health Technology Group. Healthcare Improvement Scotland.

    We recently reviewed the work of the IDEAL collaboration at an SHTG committee meeting and acknowledged the value of the framework in improving the use of evidence for non-medical technology evaluation and implementation

Leave a Reply

Your email address will not be published. Required fields are marked *